📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host. (2018)

First Author: Calvo-Pinilla E

Attributed to: Viral transmission by insect vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2018.04.015

PubMed Identifier: 29678552

Publication URI: http://europepmc.org/abstract/MED/29678552

Type: Journal Article/Review

Volume: 154

Parent Publication: Antiviral research

ISSN: 0166-3542